Pronóstico de stock pgnx
Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Stock quote and company snapshot for PROGENICS PHARMACEUTICALS INC (PGNX), including profile, stock chart, recent news and events, analyst opinions, and research reports. Progenics (PGNX) delivered earnings and revenue surprises of 18.52% and -20.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? PGNX. earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank 8/9/2017 · Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today The market couldn't see past a precipitous drop in royalty revenue during the first quarter. Progenics Pharmaceuticals, Inc. (PGNX) is trending up in the market in today’s trading session. The stock, focused in the biotechnology space, is currently trading at $5.50 after gaining 11.11% so far today. As it relates to biotech stocks, there are several aspects that have the potential to lead to movement in the market.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period. FactSet calculates the Market Cap for the basic symbol to include common shares only.
Find the latest analyst research for Progenics Pharmaceuticals Inc. Common Stock (PGNX) at Nasdaq.com. 20 Dec 2019 Real-time trade and investing ideas on Progenics Pharmaceuticals Inc. PGNX from the largest community of traders and investors. 8/9/2019 · Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock quote for Progenics Pharmaceuticals Inc. Common Stock Common Stock (PGNX) with real-time last sale and extended hours stock prices, company news, charts, and PGNX | Complete Progenics Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Stock screener for investors and traders, financial visualizations.
Technical stock forecast for PGNX: Progenics Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will Real-time trade and investing ideas on Progenics Pharmaceuticals Inc. PGNX from the largest community of traders and investors. 1/1/2020 · Here is What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX) "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). 8/1/2018 · Progenics Pharmaceuticals received a critical approval from the FDA on Monday. The shares have dropped some 10% since then in some buy the rumor, sell the news PGNX Real Time Stock Quote - Get Progenics Pharmaceuticals Inc. Common Stock (PGNX) last sale data in real-time at NASDAQ.com. PGNX stock forecast Our latest prediction for Progenics Pharmaceuticals, Inc.'s stock price was made on the Sept. 9, 2019 when the stock price was at 5.01$. In the short term (2weeks), PGNX's stock price should outperform the market by 3.46%. 12/11/2018 · Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
View Progenics Pharmaceuticals' (NASDAQ:PGNX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. 3 analysts have issued 1-year price objectives for Progenics Pharmaceuticals' stock. Their forecasts range from $10.00 to $14.00. On average, they expect Progenics Pharmaceuticals' stock price to reach $12.00 in the next year. This suggests a possible upside of 135.8% from the stock's current price. Technical stock forecast for PGNX: Progenics Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will
Progenics Pharmaceuticals, Inc. (PGNX) is trending up in the market in today’s trading session. The stock, focused in the biotechnology space, is currently trading at $5.50 after gaining 11.11% so far today. As it relates to biotech stocks, there are several aspects that have the potential to lead to movement in the market.
PGNX stock quote information – including stock price, key financials, stock charts and investing ideas containing PGNX. 12/30/2019 · Real time Progenics Pharmaceuticals (PGNX) stock price quote, stock graph, news & analysis. You can buy and sell Progenics Pharmaceuticals (PGNX) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. 2,264 people own Progenics Pharmaceuticals on Robinhood on December 31, 2019. Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and
3 analysts have issued 1-year price objectives for Progenics Pharmaceuticals' stock. Their forecasts range from $10.00 to $14.00. On average, they expect Progenics Pharmaceuticals' stock price to reach $12.00 in the next year. This suggests a possible upside of 135.8% from the stock's current price. Technical stock forecast for PGNX: Progenics Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will Real-time trade and investing ideas on Progenics Pharmaceuticals Inc. PGNX from the largest community of traders and investors. 1/1/2020 · Here is What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX) "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). 8/1/2018 · Progenics Pharmaceuticals received a critical approval from the FDA on Monday. The shares have dropped some 10% since then in some buy the rumor, sell the news PGNX Real Time Stock Quote - Get Progenics Pharmaceuticals Inc. Common Stock (PGNX) last sale data in real-time at NASDAQ.com.